Article

MDs Get More iPhone Apps

Author(s):

Even if you're tired of combing through the iPhone App Store's 75,000+ applications for something that might help around the office, Webahn has two more for you.

Even if you're tired of combing through the iPhone App Store's 75,000+ applications for something that might help around the office, Webahn has two more for you. One empowers physicians with electronic medical record access, and the other provides an online transcription service.

The first application from Webahn is called Capzule. Capzule enables physicians to access patient information remotely withe their iPhones while away from the office. It also has the capability to send messages, add notes, prescribe medications and write orders. Capzule offers a few other notable features, including integrated scheduling to track agendas, inter-office communications to always be in touch, and a chart visualizer that displays vital statistics, workflows, and automated billing.

Iqbal Boxwala, MD of Hematology and Oncology Consultants, PC, explains that, "Capzule has greatly improved our physicians quality of life because they can now access charts at anytime from anywhere."

Solo practice plans for Capzule start at $50 per month.

The second is called Accent. Accent allows physicians to dictate patient notes and letters on the iPhone and send them to OvernightScribe.com for transcription. Accent lets users edit audio files and tag dictations with key information. It also features search capability and the ability to access dictations from desktop PCs over Wi-Fi. Plans start at just 9 cents.

"We are upgrading the tools that physicians rely on most to access and update patient data," Vinu Nair, Webahn CEO, said in a prepared statement. "Browsing charts on desktops and dictating onto telephone systems or digital recorders make less sense, when you have a mobile device like iPhone which can do much more and much better."

Related Videos
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.